OverviewSuggest Edit

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. It develops drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology. The company offers its products to primary care and specialty care physicians through distributors and local representative offices.

TypePublic
Founded1999
HQCambridge, GB
Websiteastrazeneca.com
Employee Ratings4.2
Overall CultureB

Latest Updates

Employees (est.) (Dec 2019)70,600(+10%)
Job Openings1
Revenue (FY, 2019)$24.4 B(+11%)
Share Price (Jan 2021)£75.9
Cybersecurity ratingBMore

Key People/Management at AstraZeneca

Pascal Soriot

Pascal Soriot

Executive Director and CEO
Marc Dunoyer

Marc Dunoyer

Executive Director and Chief Financial Officer
Katarina Ageborg

Katarina Ageborg

Executive Vice-President, Sustainability and Chief Compliance Officer; President AstraZeneca Sweden
Pam Cheng

Pam Cheng

Executive Vice-President, Operations and Information Technology
Ruud Dobber

Ruud Dobber

Executive Vice-President, BioPharmaceuticals Business Unit
David Fredrickson

David Fredrickson

Executive Vice-President, Oncology Business Unit
Show more

AstraZeneca Office Locations

AstraZeneca has offices in Cambridge, Harlow, London, Luton and in 107 other locations
Cambridge, GB (HQ)
1 Francis Crick Ave
Cambridge, GB
136 Hills Rd
Harlow, GB
Lovet Rd
London, GB
110 Bishopsgate
London, GB
15 Stanhope Gate
Luton, GB
600 Capability Green
Show all (119)

AstraZeneca Financials and Metrics

AstraZeneca Revenue

Embed Graph
View revenue for all periods
AstraZeneca's revenue was reported to be $24.38 b in FY, 2019 which is a 10.4% increase from the previous period.
USD

Revenue (Q3, 2020)

6.6b

Gross profit (Q3, 2020)

5.2b

Gross profit margin (Q3, 2020), %

79.2%

Net income (Q3, 2020)

651.0m

EBIT (Q3, 2020)

1.2b

Market capitalization (15-Jan-2021)

99.7b

Closing stock price (15-Jan-2021)

75.9

Cash (30-Sept-2020)

8.1b

EV

113.9b
AstraZeneca's current market capitalization is £99.7 b.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

22.5b22.1b24.4b

Revenue growth, %

(2%)(2%)10%

Cost of goods sold

4.3b4.9b4.9b

Gross profit

18.1b17.2b19.5b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

5.4b5.1b6.2b5.2b5.2b5.3b5.5b5.8b6.4b6.4b6.3b6.6b

Cost of goods sold

894.0m950.0m1.2b1.1b1.0b1.2b1.1b1.1b1.4b1.4b984.0m1.4b

Gross profit

4.5b4.1b5.0b4.0b4.1b4.2b4.4b4.8b5.1b4.9b5.3b5.2b

Gross profit Margin, %

83%81%80%78%80%78%79%82%79%78%84%79%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

3.3b4.8b5.4b

Accounts Receivable

2.8b3.0b3.6b

Inventories

3.0b2.9b3.2b

Current Assets

13.2b15.6b15.6b
Quarterly
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

2.9b2.1b1.2b

Depreciation and Amortization

3.0b3.8b3.8b

Inventories

(548.0m)(13.0m)(316.0m)

Accounts Payable

415.0m(103.0m)868.0m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Depreciation and Amortization

658.0m1.3b1.9b709.0m1.4b2.1b676.0m1.4b2.1b841.0m1.6b2.4b

Cash From Operating Activities

88.0m338.0m2.6b(140.0m)(75.0m)394.0m(387.0m)491.0m1.6b139.0m1.2b3.0b

Purchases of PP&E

(286.0m)(549.0m)(849.0m)(213.0m)(486.0m)(728.0m)(174.0m)(438.0m)(659.0m)(186.0m)(370.0m)(598.0m)

Cash From Investing Activities

(146.0m)(351.0m)(686.0m)273.0m177.0m36.0m328.0m(789.0m)(715.0m)9.0m157.0m(423.0m)
USDQ1, 2017

Debt/Equity

1.2 x

Debt/Assets

0.3 x

Financial Leverage

4.1 x

P/E Ratio

71.0
Show all financial metrics

AstraZeneca Operating Metrics

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Projects in R&D Pipeline

99 133 146 132 144 149 167

Phase I Trials Projects

33 24 44 41 50 38 34

Phase II Trials Projects

27 11 33 36 37 43 50

Phase III Trials Projects

19 11 35 27 23 22 27
Show all operating metrics

AstraZeneca Acquisitions / Subsidiaries

Company NameDateDeal Size
Alexion PharmaceuticalsDecember 12, 2020$39 b
Takeda Respiratory BusinessMay 10, 2016$575 m
AcertaPharmaDecember 17, 2015$4 b
ZS PharmaNovember 06, 2015$2.70 b
AlmirallJuly 30, 2014
Pearl TherapeuticsJune 10, 2013$1.20 b
Omthera PharmaceuticalsMay 29, 2013$323 m
Ardea BiosciencesApril 23, 2012$781 m
Guangdong BeiKang Pharmaceutical Company LtdDecember 08, 2011
NovexelDecember 23, 2009
Show more

AstraZeneca Revenue Breakdown

Embed Graph

AstraZeneca revenue breakdown by business segment: 10.7% from Other Disease Areas, 22.1% from Respiratory, Inflammation and Autoimmunity, 35.5% from Oncology, 28.3% from Cardiovascular and Metabolic Diseases and 3.4% from Other

AstraZeneca revenue breakdown by geographic segment: 17.1% from Continental Europe, 38.3% from Americas, 37.2% from Asia, Africa & Australasia and 7.5% from UK

Human Capital Metrics

Embed Graph
Show all human capital metrics

AstraZeneca Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

AstraZeneca Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

AstraZeneca Online and Social Media Presence

Embed Graph

AstraZeneca Company Culture

  • Overall Culture

    B

    70/100

  • CEO Rating

    B

    70/100

  • Compensation

    A+

    81/100

Learn more on Comparably

AstraZeneca News and Updates

Insights on the Hairy Cell Leukemia Drugs Global Market to 2025 - Players Include Amgen, Astex Therapeutics and AstraZeneca Among Others

Dublin, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The "Hairy Cell Leukemia Drugs Market Research Report by Product Type (Chemotherapy Drug and Immunotherapy Drug), by Distribution Channel (Cancer Research Organization, Hospitals, Long Term Care Centers, and Pharmacies) - Global Forecast to 2025 - Cumulati…

Philippines to Get 20 Million Additional Doses From AstraZeneca

Philippines to Get 20 Million Additional Doses From AstraZeneca

HRH The Prince of Wales unveils new sustainability charter, backed by the likes of Bank of America and AstraZeneca

Summary List PlacementHis Royal Highness The Prince of Wales has unveiled a new sustainability charter, named "Terra Carta," backed by leading international businesses, including Bank of America, BlackRock, Unilever, AstraZeneca and BP. The charter, designed by Apple's former Chief Design Officer …

Thinking about trading options or stock in Moderna, Plug Power, Aurora Cannabis, AstraZeneca, or Bank of America?

NEW YORK, Jan. 6, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, PLUG, ACB, AZN, and BAC. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

COVID-19 Live Updates: UK Man Becomes First Patient In The World To Receive AstraZeneca Vaccine

HuffPost reporters are tracking the latest news on the COVID-19 pandemic.

Thinking about buying stock in AzurRx BioPharma, AstraZeneca, Marathon Patent Group, Mogo Inc, or Phunware?

NEW YORK, Jan. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AZRX, AZN, MARA, MOGO, and PHUN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

AstraZeneca Frequently Asked Questions

  • When was AstraZeneca founded?

    AstraZeneca was founded in 1999.

  • Who are AstraZeneca key executives?

    AstraZeneca's key executives are Pascal Soriot, Marc Dunoyer and Katarina Ageborg.

  • How many employees does AstraZeneca have?

    AstraZeneca has 70,600 employees.

  • What is AstraZeneca revenue?

    Latest AstraZeneca annual revenue is $24.4 b.

  • What is AstraZeneca revenue per employee?

    Latest AstraZeneca revenue per employee is $345.4 k.

  • Who are AstraZeneca competitors?

    Competitors of AstraZeneca include Daiichi Sankyo, Boehringer Ingelheim and Sanofi.

  • Where is AstraZeneca headquarters?

    AstraZeneca headquarters is located at 1 Francis Crick Ave, Cambridge.

  • Where are AstraZeneca offices?

    AstraZeneca has offices in Cambridge, Harlow, London, Luton and in 107 other locations.

  • How many offices does AstraZeneca have?

    AstraZeneca has 119 offices.